Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilon HealthAGL -1.84%68 Debt-to-Equity is 0.13 as of Jun. 2026, which is 117% above its 10-year median of 0.06. GuruFocus rates AGL with a GF Score™ of 68/100 and a GF Value™ of $91.87 (Fairly Valued). The stock has 3 warning signs investors should review. Among 559 Healthcare Providers & Services companies, Agilon Health ranks better than 74.06% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Agilon Health's Debt-to-Equity or its related term are showing as below:
AGL'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.35 Med: 0.06 Max: 0.29
Current: 0.15
During the past 7 years, the highest Debt-to-Equity Ratio of Agilon Health was 0.29. The lowest was -0.35. And the median was 0.06.
AGL's Debt-to-Equity is ranked better than 74.06% of 559
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs AGL: 0.15
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Agilon Health Debt-to-Equity Related Terms
Agilon Health Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Agilon Health's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AGL vs INNV, HCSG, ARDT: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Agilon Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Agilon Health's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health (AGL) has a Debt-to-Equity of 0.13 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Agilon Health and its competitors. This is 117% above median its historical median of 0.06. According to the industry distribution chart, Agilon Health ranks #145 out of 559 companies in the Healthcare Providers & Services industry, placing it in the top 25.9%.
Is Agilon Health's Debt-to-Equity too high?
Agilon Health's current Debt-to-Equity of 0.13 is 117% above median its 10-year median of 0.06. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Agilon Health's value of 0.13 is 69% below this industry median. Based on the distribution chart, Agilon Health ranks #145 out of 559 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Agilon Health has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Debt-to-Equity compare to INNV and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #145 out of 559 companies for Debt-to-Equity. This puts Agilon Health in the upper half of its industry. The industry median Debt-to-Equity is 0.42. Agilon Health's value of 0.13 is 69% below this benchmark. While the company's 10-year median is 0.06 vs. the industry median of 0.42, Agilon Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilon Health's current Debt-to-Equity of 0.13 is 69% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Agilon Health and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilon Health's current Debt-to-Equity is 0.13, which is 117% above median its own 10-year median of 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Fairly Valued. The stock's GF Value™ is $91.87, compared to a current price of $93.64 — trading 1.9% above its estimated fair value. The current Debt-to-Equity is 0.13, which is 117% above median its 10-year median of 0.06 and 69% below the Healthcare Providers & Services industry median of 0.42. Agilon Health's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Agilon Health (AGL), the current Debt-to-Equity is 0.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $93.64 is trading 1.9% above its estimated GF Value™ of $91.87.
GuruFocus considers Agilon Health to be Fairly Valued.
Key valuation signals for AGL:
Debt-to-Equity: 0.13 (117% above median its 10-year median of 0.06)
GF Value™: $91.87 vs. price of $93.64 (1.9% above fair value)
Industry Position: 69% below the Healthcare Providers & Services median (#145 of 559)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
68GF Score
Get the complete analysis for AGL
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
